GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target On December 10, HSBC analyst Rajesh Kumar raised the firm’s price target on GSK plc (NYSE:GSK) to 1,500 GBp from 1,200 GBp and kept a Reduce rating on the shares. The move came as part of HSBC’s 2026 outlook for the pharmaceutical sector. The firm said the group is positioned to outperform next year, “even more so if AI panic kicks in.” HSBC add ...